Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 56,441,980
  • Shares Outstanding, K 400,525
  • Annual Sales, $ 803,400 K
  • Annual Income, $ -747,060 K
  • 60-Month Beta 1.39
  • Price/Sales 66.74
  • Price/Cash Flow N/A
  • Price/Book 20.68
Trade MRNA with:

Options Overview

Details
  • Implied Volatility 60.02%
  • Historical Volatility 75.27%
  • IV Percentile 1%
  • IV Rank 3.61%
  • IV High 139.76% on 04/20/20
  • IV Low 57.04% on 03/23/21
  • Put/Call Vol Ratio 0.48
  • Today's Volume 79,735
  • Volume Avg (30-Day) 42,757
  • Put/Call OI Ratio 0.95
  • Today's Open Interest 439,451
  • Open Int (30-Day) 348,344

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/21
See More
  • Average Estimate 2.64
  • Number of Estimates 5
  • High Estimate 4.26
  • Low Estimate 1.95
  • Prior Year -0.35
  • Growth Rate Est. (year over year) +854.29%

Price Performance

See More
Period Period Low Period High Performance
1-Month
117.34 +27.59%
on 03/30/21
157.75 -5.10%
on 03/16/21
+12.72 (+9.29%)
since 03/12/21
3-Month
117.34 +27.59%
on 03/30/21
189.26 -20.90%
on 02/08/21
+25.65 (+20.68%)
since 01/13/21
52-Week
33.15 +351.61%
on 04/14/20
189.26 -20.90%
on 02/08/21
+116.81 (+355.05%)
since 04/13/20

Most Recent Stories

More News
Moderna Provides Clinical and Supply Updates on COVID-19 Vaccine Program Ahead of 2nd Annual Vaccines Day

--Antibody persistence data out to 6 months published in The New England Journal of Medicine

MRNA : 149.71 (+7.40%)
Consumer Price Index Rise 0.6%

Consumer Price Index Rise 0.6%

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
CPI +0.6%: Higher, but Not Scary; JNJ Vax on Hold?

Headline CPI last month reached +0.6%, 10 basis points ahead of consensus, and the highest single-month tally since June of 2009.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
Thinking about trading options or stock in Moderna, BioNTech, AstraZeneca, Overstock.com, or GrubHub?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for MRNA, BNTX, AZN, OSTK, and GRUB.

AZN : 49.19 (-0.47%)
BNTX : 129.64 (+6.68%)
MRNA : 149.71 (+7.40%)
OSTK : 77.75 (+7.55%)
GRUB : 72.00 (+7.61%)
Bristol Myers' (BMY) Opdivo Combo Encouraging in NSCLC study

Bristol Myers Squibb (BMY) announces positive results from a late-stage study evaluating Opdivo plus chemotherapy for resectable NSCLC.

RHHBY : 41.6900 (+0.29%)
MRK : 76.43 (+0.28%)
MRNA : 149.71 (+7.40%)
BMY : 63.58 (+1.42%)
Has Moderna (MRNA) Outpaced Other Medical Stocks This Year?

Is (MRNA) Outperforming Other Medical Stocks This Year?

MRNA : 149.71 (+7.40%)
Stock Market News for Apr 12, 2021

Benchmarks hit record levels on Friday, closing in the green for consecutive weeks as investors shrugged off inflation fears and focused on quarterly earnings season amid reopening optimism

UNH : 374.50 (-0.47%)
AMZN : 3,400.00 (+0.61%)
AAPL : 134.43 (+2.43%)
PFE : 37.16 (+0.51%)
HON : 229.00 (+0.17%)
MRNA : 149.71 (+7.40%)
CRM : 232.00 (+1.42%)
ALGN : 595.63 (-0.91%)
CPRT : 117.53 (-0.66%)
GOOGL : 2,254.43 (+0.44%)
OKTA : 265.32 (+6.57%)
J&J's (JNJ) COVID-19 Jab Under EU Review for Rare Blood Clots

The European drug regulator's safety committee is conducting a review to asses a link between J&J's (JNJ) COVID-19 vaccine and rare blood clots.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
BNTX : 129.64 (+6.68%)
Bristol Myers' (BMY) Opdivo Combo Positive in ESCC Study

Bristol Myers (BMY) announces encouraging data from the late-stage study evaluating Opdivo plus chemotherapy and Opdivo plus Yervoy in ESCC study.

RHHBY : 41.6900 (+0.29%)
MRK : 76.43 (+0.28%)
MRNA : 149.71 (+7.40%)
BMY : 63.58 (+1.42%)
ImmunityBio (IBRX) Reports Positive COVID-19 Vaccine Data

ImmunityBio (IBRX) reports positive initial data on its COVID-19 vaccine candidate in healthy phase I study participants.

JNJ : 159.48 (-1.34%)
PFE : 37.16 (+0.51%)
MRNA : 149.71 (+7.40%)
IBRX : 16.76 (+4.16%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 159.52
2nd Resistance Point 155.82
1st Resistance Point 152.76
Last Price 149.71
1st Support Level 146.00
2nd Support Level 142.30
3rd Support Level 139.24

See More

52-Week High 189.26
Last Price 149.71
Fibonacci 61.8% 129.63
Fibonacci 50% 111.21
Fibonacci 38.2% 92.78
52-Week Low 33.15

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar